Paper39698259
Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders.
Saxena SK and 10 others. ACS Pharmacol Transl Sci, 2024. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders. Papers, record 39698259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39698259
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References111
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22229116 | Neuropathological alterations in Alzheimer disease. | Cold Spring Harb Perspect Med | 2011 | https://conductscience.org/library/papers/22229116 | PubMed |
| 2 | 32303714 | Author Correction: Dynamics of oligomer populations formed during the aggregation of Alzheimer's Aβ42 peptide. | Nat Chem | 2020 | https://conductscience.org/library/papers/32303714 | PubMed |
| 3 | 25523424 | Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. | Curr Alzheimer Res | 2015 | https://conductscience.org/library/papers/25523424 | PubMed |
| 4 | 14687544 | Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. | Neuron | 2003 | https://conductscience.org/library/papers/14687544 | PubMed |
| 5 | 29481488 | Neprilysin in the Cerebrospinal Fluid and Serum of Patients Infected With HIV1-Subtypes C and B. | J Acquir Immune Defic Syndr | 2018 | https://conductscience.org/library/papers/29481488 | PubMed |
| 6 | 36523572 | Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019. | Front Public Health | 2022 | https://conductscience.org/library/papers/36523572 | PubMed |
| 7 | 3516994 | Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin. | J Biol Chem | 1986 | https://conductscience.org/library/papers/3516994 | PubMed |
| 8 | 17585404 | Neurological disorders affect millions globally. | J Environ Health | 2007 | https://conductscience.org/library/papers/17585404 | PubMed |
| 9 | 14749444 | Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. | J Neurosci | 2004 | https://conductscience.org/library/papers/14749444 | PubMed |
| 10 | 24391587 | Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease. | Front Aging Neurosci | 2013 | https://conductscience.org/library/papers/24391587 | PubMed |
| 11 | 10676850 | What the evolution of the amyloid protein precursor supergene family tells us about its function. | Neurochem Int | 2000 | https://conductscience.org/library/papers/10676850 | PubMed |
| 12 | 15293994 | Solution structure of amyloid beta-peptide (25-35) in different media. | J Med Chem | 2004 | https://conductscience.org/library/papers/15293994 | PubMed |
| 13 | 19773363 | Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. | J Cell Sci | 2009 | https://conductscience.org/library/papers/19773363 | PubMed |
| 14 | 12972166 | Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. | Neurosci Lett | 2003 | https://conductscience.org/library/papers/12972166 | PubMed |
| 15 | 15860464 | Mutation screening and association study of the neprilysin gene in sporadic Alzheimer's disease in Chinese persons. | J Gerontol A Biol Sci Med Sci | 2005 | https://conductscience.org/library/papers/15860464 | PubMed |
| 16 | 15778722 | Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. | Nat Med | 2005 | https://conductscience.org/library/papers/15778722 | PubMed |
| 17 | 12657655 | Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. | J Neurosci | 2003 | https://conductscience.org/library/papers/12657655 | PubMed |
| 18 | 31266021 | Associations of Neprilysin Activity in CSF with Biomarkers for Alzheimer's Disease. | Neurodegener Dis | 2019 | https://conductscience.org/library/papers/31266021 | PubMed |
| 19 | 11375493 | Metabolic regulation of brain Abeta by neprilysin. | Science | 2001 | https://conductscience.org/library/papers/11375493 | PubMed |
| 20 | 34239348 | Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease. | Int J Biol Sci | 2021 | https://conductscience.org/library/papers/34239348 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42633327 | Magnetoreceptive CRY/MagR complexes: linking circadian redox signalling to protein aggregation in Alzheimer's and Parkinson's disease. | ADMET DMPK | 2026 | https://conductscience.org/library/papers/42633327 | PubMed |
| 42438074 | Combating ageing beyond the cell: Emerging roles of extracellular proteostasis. | FEBS J | 2026 | https://conductscience.org/library/papers/42438074 | PubMed |
| 42237901 | The expanding role of protease therapeutics (2012-2026): from replacement therapies to immune system modulation and beyond. | Biochem J | 2026 | https://conductscience.org/library/papers/42237901 | PubMed |
| 42072660 | Mast Cells and Substance P: Neuroinflammatory Loops at the Molecular and Translational Clinical Levels. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072660 | PubMed |
| 41834915 | Bridging pathologies: Mechanistic insights into the diabetes-Alzheimer's nexus. | EXCLI J | 2026 | https://conductscience.org/library/papers/41834915 | PubMed |
| 41683989 | From Traumatic Brain Injury to Alzheimer's Disease: Multilevel Biomechanical, Neurovascular, and Molecular Mechanisms with Emerging Therapeutic Directions. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683989 | PubMed |
| 41670689 | Intranasal CM-hMSCs modulate brain gene expression linked to glucose metabolism and inflammation in male and female rats exposed to maternal and post-weaning high-fat diets. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41670689 | PubMed |
| 41589495 | Enzymatic Biomarkers for Early Diagnosis of Alzheimer's Disease: Uncovering Key Targets and Mechanisms. | CNS Neurol Disord Drug Targets | 2026 | https://conductscience.org/library/papers/41589495 | PubMed |
| 41014460 | Targeting the awry Aβ pathway in Alzheimer's disease: hype and hurdles. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41014460 | PubMed |
| 41009633 | Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer's Disease and HIV-Associated Neurocognitive Disorders. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009633 | PubMed |
| 41007730 | Intrathecal Therapies for Neurodegenerative Diseases: A Review of Current Approaches and the Urgent Need for Advanced Delivery Systems. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007730 | PubMed |
| 40627107 | Exosome-Mediated Delivery of Amyloid Beta Modulators: A Potential Therapeutic Strategy for Alzheimer's Disease. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40627107 | PubMed |
| 40581884 | Neprilysin regulates the progression of glioblastoma: an in-vitro study using siRNA mediated gene silencing and HDAC1 mediated upregulation of neprilysin in U87 MG cells. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/40581884 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| KNG1 | 3827 | PubTator's text mining | https://conductscience.org/library/genes/3827 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| MME | 4311 | PubTator's text mining | https://conductscience.org/library/genes/4311 | NCBI Gene |
| TAC1 | 6863 | PubTator's text mining | https://conductscience.org/library/genes/6863 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39698259
GET https://conductscience.org/api/papers/v1/39698259/references?page=2